A panel of experts discusses the current landscape of multi-cancer early detection, addressing its potential to broaden access and improve cancer screening, emphasizing the importance of clinical trials and equitable healthcare distribution.
September 29th 2023
A panel of esteemed cancer experts explore the challenges and opportunities in cancer screening and identification, shedding light on the evolving landscape and its impact on clinical practice.
Explore critical issues surrounding health disparities in cancer screening, as discussed by experts, and the urgent need to bridge gaps in access, trust, and follow-up care for underserved populations.
October 17th 2023
Expert panelists delve into multicancer early detection testing and discuss its potential to revolutionize cancer screening, close healthcare gaps, and complement standard care approaches.
The potential of MCED testing to reduce health inequities and an examination of accessibility, including FDA approval, physician education, patient awareness, affordability, and logistical support.
October 24th 2023
Shared insight into findings of the DETECT-A study, a prospective interventional trial, covering feasibility, safety, and performance of multicancer early detection tests in a healthcare system setting.
Panelists explore recent findings of the PATHFINDER study, focusing on the objectives, study design, key results, and differences from previous studies, shedding light on the potential of early cancer detection tests.
October 31st 2023
Discover the potential clinical implications of groundbreaking cancer screening studies, DETECT-A and PATHFINDER, and the evolving landscape of multi-cancer early detection.
Key opinion leaders review the rationale behind multi-biomarker approaches and how they're shaping the future of cancer detection and research.
November 7th 2023
Expert perspectives about the ASCEND trial, its study design, and the critical role it plays in developing advanced cancer detection methods.
Shared insight into the efficiency of diagnostic resolution approaches, comparing imaging-based and molecular tissue of origin strategies in multi-cancer early detection testing.